Xenetic Biosciences, Inc. — Form D
Xenetic Biosciences, Inc. of FRAMINGHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-13. The offering totals $489K, of which $489K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-10-13
- Form: D
- Accession: 0001200876-22-000032
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $489K
- Amount sold: $489K
- Investors: 1
- Date of first sale: 2022-10-12
- Security types: equity
- Revenue range: $1,000,001 - $5,000,000
- SEC file number: 021-461635
Issuer
- Name: Xenetic Biosciences, Inc.
- CIK: 0001534525
- Entity type: Corporation
- Jurisdiction: NEVADA
- Address: 945 CONCORD ST., FRAMINGHAM, MA, 01701
- Phone: 781-778-7720
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Grigory Borisenko | Director | SAN DIEGO, CA |
| James Callaway | Director | Framingham, MA |
| Firdaus Dastoor | Director | Framingham, MA |
| Jeffrey Eisenberg | Director | Framingham, MA |
| Roger Kornberg | Director | Framingham, MA |
| Adam Logal | Director | Framingham, MA |
| Alexey Vinogradov | Director | Charlottesville, VA |
| Jeffrey Eisenberg | Executive Officer | Framingham, MA |
| Curtis Lockshin | Executive Officer | Framingham, MA |
| James Parslow | Executive Officer | Framingham, MA |
| Curtis Lockshin | Director | Framingham, MA |
| Roman Knyazev | Director | Framingham, MA |
| Dmitry Genkin | Director | Framingham, MA |
Other filings by this issuer (4)
More